Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

Atherosclerosis

Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880 · see citing works

The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation

Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525 · see citing works

Atherosclerosis

Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,049 · see citing works

PPAR-γ agonists inhibit production of monocyte inflammatory cytokines

Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899 · see citing works

Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ

Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H.-W., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,861 · see citing works

PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL

Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomázy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,800 · see citing works

Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice

Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574 · see citing works

A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis

Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347 · see citing works

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

Suzuki, H. I., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al. (1997) · Nature · doi:10.1038/386292a0 · Cited by 1,226 · see citing works

PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001) · Nature Medicine · doi:10.1038/83336 · Cited by 1,069 · see citing works

Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide.

Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., & Murphy, W. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9730 · Cited by 1,066 · see citing works

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,037 · see citing works

15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway

Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004 · see citing works

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G. J., Goodman, J., Hagger, G. N., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112059299 · Cited by 950 · see citing works

Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors

Joseph, S. B., Laffitte, B. A., Patel, P. H., Watson, M. A., Matsukuma, K. E., Walczak, R., Collins, J. L., Osborne, T. F., & Tontonoz, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111041200 · Cited by 779 · see citing works

The Role of Orphan Nuclear Receptors in the Regulation of Cholesterol Homeostasis

Repa, J. J., & Mangelsdorf, D. J. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.459 · Cited by 762 · see citing works

27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells

Fu, X., Menke, J. G., Chen, Y., Zhou, G., MacNaul, K. L., Wright, S. D., Sparrow, C. P., & Lund, E. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105805200 · Cited by 573 · see citing works

The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain

Nissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559 · see citing works

Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.

Galis, Z. S., Sukhova, G. K., Kranzhöfer, R., Clark, S. C., & Libby, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.402 · Cited by 557 · see citing works

The role of PPAR-γ in macrophage differentiation and cholesterol uptake

Moore, K. J., Rosen, E. D., Fitzgerald, M. L., Randow, F., Andersson, L. P., Altshuler, D., Milstone, D. S., Mortensen, R. M., Spiegelman, B. M., & Freeman, M. W. (2001) · Nature Medicine · doi:10.1038/83328 · Cited by 513 · see citing works

Identification of macrophage liver X receptors as inhibitors of atherosclerosis

Tangirala, R. K., Bischoff, E. D., Joseph, S. B., Wagner, B. L., Walczak, R., Laffitte, B. A., Daige, C. L., Thomas, D., Heyman, R. A., Mangelsdorf, D. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182199799 · Cited by 440 · see citing works

Targeted Disruption of the Matrix Metalloproteinase-9 Gene Impairs Smooth Muscle Cell Migration and Geometrical Arterial Remodeling

Galis, Z. S., Johnson, C., Godin, D., Magid, R., Shipley, J. M., Senior, R. M., & Ivan, E. (2002) · Circulation Research · doi:10.1161/01.res.0000041036.86977.14 · Cited by 417 · see citing works

The liver X receptor gene team: Potential new players in atherosclerosis

Repa, J. J., & Mangelsdorf, D. J. (2002) · Nature Medicine · doi:10.1038/nm1102-1243 · Cited by 387 · see citing works

Salmonella spp. are cytotoxic for cultured macrophages

Chen, L.-M., Kaniga, K., & Galán, J. E. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.471410.x · Cited by 379 · see citing works

Peroxisome Proliferator-Activated Receptor γ-Dependent Repression of the Inducible Nitric Oxide Synthase Gene

Li, M., Pascual, G., & Glass, C. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4699-4707.2000 · Cited by 377 · see citing works

Autoregulation of the Human Liver X Receptor α Promoter

Laffitte, B. A., Joseph, S. B., Walczak, R., Pei, L., Wilpitz, D. C., Collins, J. L., & Tontonoz, P. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7558-7568.2001 · Cited by 316 · see citing works

Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery

Pasterkamp, G., Schoneveld, A. H., Hijnen, D., de Kleijn, D. P. V., Teepen, H. L. J. M., van der Wal, A. C., & Borst, C. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00371-8 · Cited by 298 · see citing works

Inhibition of IκB Kinase and IκB Phosphorylation by 15-Deoxy-Δ12,14-Prostaglandin J2 in Activated Murine Macrophages

Castrillo, A., Díaz-Guerra, M. J. M., Hortelano, S., Martín‐Sanz, P., & Boscá, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1692-1698.2000 · Cited by 264 · see citing works

Genetic Deficiency of Inducible Nitric Oxide Synthase Reduces Atherosclerosis and Lowers Plasma Lipid Peroxides in Apolipoprotein E–Knockout Mice

Kuhlencordt, P. J., Chen, J., Han, F., Astern, J., & Huang, P. L. (2001) · Circulation · doi:10.1161/01.cir.103.25.3099 · Cited by 252 · see citing works

Cross-talk between glucocorticoid receptor and AP-1

Herrlich, P. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204388 · Cited by 229 · see citing works

Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice

Detmers, P. A., Hernandez, M., Mudgett, J. S., Hassing, H., Burton, C. A., Mundt, S. S., Chun, S. H., Fletcher, D. S., Card, D., Lisnock, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3430 · Cited by 206 · see citing works

Topical Peroxisome Proliferator Activated Receptor-α Activators Reduce Inflammation in Irritant and Allergic Contact Dermatitis Models

Sheu, M. Y., Fowler, A. J., Kao, J. S., Schmuth, M., Fluhr, J. W., Man, M., Elias, P. M., Feingold, K. R., Schoonjans, K., & Auwerx, J. H. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01626.x · Cited by 176 · see citing works

AP-1--glucocorticoid receptor crosstalk taken to a higher level

Karin, M., & Chang, L. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690447 · Cited by 167 · see citing works

Redundancy in the Signaling Pathways and Promoter Elements Regulating Cyclooxygenase-2 Gene Expression in Endotoxin-treated Macrophage/Monocytic Cells

MESTRE, J. R., Mackrell, P. J., Rivadeneira, D. E., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005077200 · Cited by 150 · see citing works

Inhibition of the Nuclear Factor κB (NF-κB) Pathway by Tetracyclic Kaurene Diterpenes in Macrophages

Castrillo, A., Heras, B. D. L., Hortelano, S., Rodrı́guez, B., Villar, Á., & Boscá, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100010200 · Cited by 113 · see citing works

Inflammation and immune response in atherosclerosis

Hansson, G. K. (1999) · Current Atherosclerosis Reports · doi:10.1007/s11883-999-0011-0 · Cited by 83 · see citing works

Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins

Callejas, N. A., Boscá, L., Williams, C. S., DuBois, R. N., & Martín‐Sanz, P. (2000) · Gastroenterology · doi:10.1053/gast.2000.9374 · Cited by 62 · see citing works

Oxidized cholesterol in oxidized low density lipoprotein may be responsible for the inhibition of LPS-induced nitric oxide production in macrophages1The project was supported by National Natural Science Foundation of China.1

Liu, S.-X., Chen, Y., Zhou, M., et al. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00185-8 · Cited by 21 · see citing works

Orphan nuclear receptors find a home in the arterial wall

Laffitte, B. A., & Tontonoz, P. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0022-6 · Cited by 20 · see citing works

CD36 mediates binding of soluble thrombospondin-1 but not cell adhesion and haptotaxis on immobilized thrombospondin-1

Magnetto, S., Bruno-Bossio, G., Voland, C., Lecerf, J. M., Lawler, J., Delmas, P. D., Silverstein, R. L., & Clézardin, P. (1998) · Cell Biochemistry and Function · doi:10.1002/(sici)1099-0844(199809)16:3 · Cited by 19 · see citing works

Inflammation and metabolic disorders

Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · see citing works

Inflammation, stress, and diabetes

Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143 · see citing works

Macrophage death and defective inflammation resolution in atherosclerosis

Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120 · see citing works

Liver X receptors as integrators of metabolic and inflammatory signaling

Zelcer, N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27883 · Cited by 978 · see citing works

Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response

Rosenfeld, M. G., Lunyak, V. V., & Glass, C. K. (2006) · Genes & Development · doi:10.1101/gad.1424806 · Cited by 952 · see citing works

Inflammatory mechanisms in the regulation of insulin resistance

Tilg, H., & Moschen, A. R. (2008) · Molecular Medicine · doi:10.2119/2007-00119.tilg · Cited by 779 · see citing works

Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR

Calkin, A. C., & Tontonoz, P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3312 · Cited by 779 · see citing works

Liver X receptors in lipid signalling and membrane homeostasis

Wang, B., & Tontonoz, P. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0037-x · Cited by 722 · see citing works

The bile acid receptor FXR is a modulator of intestinal innate immunity

Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655 · see citing works

Molecular determinants of crosstalk between nuclear receptors and toll-like receptors

Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647 · see citing works

Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response

Wang, Y.-D., Chen, W.-D., Wang, M., Yu, D., Forman, B. M., & Huang, W. (2008) · Hepatology · doi:10.1002/hep.22519 · Cited by 639 · see citing works

Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins

Casserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560 · see citing works

Parallel SUMOylation-Dependent Pathways Mediate Gene- and Signal-Specific Transrepression by LXRs and PPARγ

Ghisletti, S., Huang, W., Ogawa, S., Pascual, G., Lin, M.-E., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.11.022 · Cited by 561 · see citing works

Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?

Parisi, L., Gini, E., Baci, D., Tremolati, M., Fanuli, M., Bassani, B., Farronato, G., Bruno, A., & Mortara, L. (2018) · Journal of Immunology Research · doi:10.1155/2018/8917804 · Cited by 508 · see citing works

Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease

Gylling, H., Plat, J., Turley, S., Ginsberg, H. N., Ellegård, L., Jessup, W., Jones, P. J., Lütjohann, D., Maerz, W., Masana, L., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.043 · Cited by 529 · see citing works

The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance

Warrier, M., Shih, D. M., Burrows, A. C., Ferguson, D., Gromovsky, A. D., Brown, A. L., Marshall, S., McDaniel, A., Schugar, R. C., Wang, Z., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.036 · Cited by 414 · see citing works

PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis

Li, A. C., & Glass, C. K. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400010-jlr200 · Cited by 357 · see citing works

Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis

Boven, L. A., Van Meurs, M., Van Zwam, M., Wierenga-Wolf, A., Hintzen, R. Q., Boot, R. G., Aerts, J. M., Amor, S., Nieuwenhuis, E. E., & Laman, J. D. (2006) · Brain · doi:10.1093/brain/awh707 · Cited by 353 · see citing works

SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism

Oishi, Y., Spann, N. J., Link, V. M., Muse, E. D., Strid, T., Edillor, C., Kolar, M. J., Matsuzaka, T., Hayakawa, S., Tao, J., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.11.009 · Cited by 342 · see citing works

LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling

Ito, A., Hong, C., Rong, X., Zhu, X., Tarling, E. J., Hedde, P. N., Gratton, E., Parks, J., & Tontonoz, P. (2015) · eLife · doi:10.7554/elife.08009 · Cited by 281 · see citing works

Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism

Lefere, S., & Tacke, F. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.02.004 · Cited by 278 · see citing works

Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-κB target gene expression

Shah, Y. M., Ma, X., Morimura, K., Kim, I., & Gonzalez, F. J. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00528.2006 · Cited by 231 · see citing works

Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist

Litvinchuk, A., Suh, J. H., Guo, J. L., Lin, K., Davis, S. S., Bien-Ly, N., Tycksen, E., Tabor, G. T., Remolina Serrano, J., Manis, M., et al. (2024) · Neuron · doi:10.1016/j.neuron.2023.10.023 · Cited by 161 · see citing works

Nuclear receptors as therapeutic targets in cholestatic liver diseases

Zollner, G., & Trauner, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00030.x · Cited by 146 · see citing works

Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C

Lima-Cabello, E., García-Mediavilla, M. V., Miquilena-Colina, M. E., Vargas-Castrillón, J., Lozano-Rodríguez, T., Fernández-Bermejo, M., Olcoz, J. L., González-Gallego, J., García-Monzón, C., & Sánchez-Campos, S. (2011) · Clinical Science · doi:10.1042/cs20100387 · Cited by 144 · see citing works

Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease

Beaven, S. W., Wroblewski, K., Wang, J., Hong, C., Bensinger, S., Tsukamoto, H., & Tontonoz, P. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.053 · Cited by 131 · see citing works

Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses

Aho, V., Ollila, H. M., Kronholm, E., Bondia-Pons, I., Soininen, P., Kangas, A. J., Hilvo, M., Seppälä, I., Kettunen, J., Oikonen, M., et al. (2016) · Scientific Reports · doi:10.1038/srep24828 · Cited by 126 · see citing works

Food Fight: Role of Itaconate and Other Metabolites in Antimicrobial Defense

Luan, H. H., & Medzhitov, R. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.013 · Cited by 130 · see citing works

Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes

Zhang-Gandhi, C. X., & Drew, P. D. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.007 · Cited by 117 · see citing works

Δ-5 Fatty Acid Desaturase <i>FADS1</i> Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators

Gromovsky, A. D., Schugar, R. C., Brown, A. L., Helsley, R. N., Burrows, A. C., Ferguson, D., Zhang, R., Sansbury, B. E., Lee, R. G., Morton, R. E., et al. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309660 · Cited by 115 · see citing works

Crosstalk between reverse cholesterol transport and innate immunity

Azzam, K. M., & Fessler, M. B. (2012) · Trends in Endocrinology &amp; Metabolism · doi:10.1016/j.tem.2012.02.001 · Cited by 96 · see citing works

Integrated Analysis Highlights the Immunosuppressive Role of TREM2+ Macrophages in Hepatocellular Carcinoma

Zhou, L., Wang, M., Guo, H., Hou, J., Zhang, Y., Li, M., Wu, X., Chen, X., & Wang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.848367 · Cited by 85 · see citing works

Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment

Lefterov, I., Bookout, A., Wang, Z., Staufenbiel, M., Mangelsdorf, D., & Koldamova, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-20 · Cited by 89 · see citing works

Cholesterol epoxide hydrolase and cancer

Silvente-Poirot, S., & Poirot, M. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.07.007 · Cited by 82 · see citing works

Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation

Wang, Y. Y., Dahle, M. K., Ågren, J., Myhre, A. E., Reinholt, F. P., Foster, S. J., Collins, J. L., Thiemermann, C., Aasen, A. O., & Wang, J. E. (2006) · Shock · doi:10.1097/01.shk.0000191377.78144.d9 · Cited by 76 · see citing works

Modulation of ABCA1 by an LXR Agonist Reduces Beta-Amyloid Levels and Improves Outcome after Traumatic Brain Injury

Loane, D. J., Washington, P. M., Vardanian, L., Pocivavsek, A., Hoe, H.-S., Duff, K. E., Cernak, I., Rebeck, G. W., Faden, A. I., & Burns, M. P. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1595 · Cited by 57 · see citing works

Nuclear Receptors in Nonalcoholic Fatty Liver Disease

López-Velázquez, J. A., Carrillo-Córdova, L. D., Chávez-Tapia, N. C., Uribe, M., & Méndez-Sánchez, N. (2012) · Journal of Lipids · doi:10.1155/2012/139875 · Cited by 48 · see citing works

LC3-associated phagocytosis (LAP): a potentially influential mediator of efferocytosis-related tumor progression and aggressiveness

Asare, P. F., Roscioli, E., Hurtado, P. R., Tran, H. B., Mah, C. Y., & Hodge, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01298 · Cited by 50 · see citing works

Liver X receptors balance lipid stores in hepatic stellate cells through Rab18, a retinoid responsive lipid droplet protein

O'Mahony, F., Wroblewski, K., O'Byrne, S. M., Jiang, H., Clerkin, K., Benhammou, J., Blaner, W. S., & Beaven, S. W. (2015) · Hepatology · doi:10.1002/hep.27645 · Cited by 44 · see citing works

Activation of liver X receptors attenuates endotoxin-induced liver injury in mice with nonalcoholic fatty liver disease

Liu, Y., Han, X., Bian, Z., Peng, Y., You, Z., Wang, Q., Chen, X., Qiu, D., & Ma, X. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1902-9 · Cited by 35 · see citing works

Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2

Secor McVoy, J. R., Oughli, H. A., & Oh, U. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0247-2 · Cited by 34 · see citing works

The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis

Sallam, T., Ito, A., Rong, X., Kim, J., van Stijn, C., Chamberlain, B. T., Jung, M. E., Chao, L. C., Jones, M., Gilliland, T., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m047548 · Cited by 30 · see citing works

Parameter adaptations during phenotype transitions in progressive diseases

Tiemann, C. A., Vanlier, J., Hilbers, P. A., & van Riel, N. A. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-174 · Cited by 22 · see citing works

Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells

Bendre, S. V., Wang, Y., Hajyousif, B., K C, R., Bhogale, S. G., Pradeep, D., Krawczynska, N., Schane, C. P., Weisser, E., Singh, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.adx5490 · Cited by 8 · see citing works

Liver X receptors, lipids and their reproductive secrets in the male

El-Hajjaji, F.-Z., Oumeddour, A., Pommier, A., Ouvrier, A., Viennois, É., Dufour, J., Caira, F., Drevet, J. R., Volle, D. H., Baron, S., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.004 · Cited by 50 · see citing works

Liver X receptors interfere with the deleterious effect of diethylstilbestrol on testicular physiology

Oumeddour, A., Viennois, É., Caira, F., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.005 · Cited by 9 · see citing works

Recent Advances in Liver X Receptor Biology and Chemistry

Goodwin, B. J., Zuercher, W. J., & Collins, J. L. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608784535075 · Cited by 34 · see citing works

The Pharmacology of LXR

Michael, L., Schkeryantz, J. M., & Burris, T. P. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054553767 · Cited by 65 · see citing works

Therapeutic opportunities for liver X receptor modulators.

Collins, J. L. (2004) · PubMed · Cited by 37 · see citing works